Q

Qingdao NovelBeam Technology Co Ltd
SSE:688677

Watchlist Manager
Qingdao NovelBeam Technology Co Ltd
SSE:688677
Watchlist
Price: 35.68 CNY -7.76% Market Closed
Market Cap: 4.3B CNY
Have any thoughts about
Qingdao NovelBeam Technology Co Ltd?
Write Note

Qingdao NovelBeam Technology Co Ltd
Total Current Assets

Last Value
3-Years 3-Y CAGR
5-Years 5-Y CAGR
10-Years 10-Y CAGR
Quarterly
Annual
|

Qingdao NovelBeam Technology Co Ltd
Total Current Assets Peer Comparison

Competitors Analysis
Latest Figures & CAGR of Competitors

Company Total Current Assets CAGR 3Y CAGR 5Y CAGR 10Y
Q
Qingdao NovelBeam Technology Co Ltd
SSE:688677
Total Current Assets
ÂĄ904.9m
CAGR 3-Years
67%
CAGR 5-Years
45%
CAGR 10-Years
N/A
A
APT Medical Inc
SSE:688617
Total Current Assets
ÂĄ1.8B
CAGR 3-Years
71%
CAGR 5-Years
53%
CAGR 10-Years
N/A
J
Jiangsu Yuyue Medical Equipment & Supply Co Ltd
SZSE:002223
Total Current Assets
ÂĄ9.3B
CAGR 3-Years
9%
CAGR 5-Years
18%
CAGR 10-Years
19%
Shenzhen Mindray Bio-Medical Electronics Co Ltd
SZSE:300760
Total Current Assets
ÂĄ30.3B
CAGR 3-Years
12%
CAGR 5-Years
13%
CAGR 10-Years
N/A
J
Jafron Biomedical Co Ltd
SZSE:300529
Total Current Assets
ÂĄ3.2B
CAGR 3-Years
2%
CAGR 5-Years
19%
CAGR 10-Years
N/A
Shanghai United Imaging Healthcare Co Ltd
SSE:688271
Total Current Assets
ÂĄ20.2B
CAGR 3-Years
49%
CAGR 5-Years
N/A
CAGR 10-Years
N/A
No Stocks Found

Qingdao NovelBeam Technology Co Ltd
Glance View

Market Cap
4.3B CNY
Industry
Health Care

Qingdao NovelBeam Technology Co., Ltd. engages in the research and development of optics technology, the manufacture of optical instruments, and the provision of design solutions for medical, life science, laser, and micro-display projection applications. The company is headquartered in Qingdao, Shandong and currently employs 854 full-time employees. The company went IPO on 2021-02-26. Its main products of medical endoscope equipment include fluorescent endoscopes, fluorescent camera adapters/adaptive lenses, fluorescent light source modules and white light source modules. Its medical endoscopic equipment products are mainly used in abdominal endoscopic surgery such as liver and gallbladder and gastrointestinal surgery. Its optical products mainly include medical optical products, industrial and laser optical products, and biometric products. Among them, the biometric products include fingerprint devices, palmprint devices and related accessories. In addition, the Company also provides technical services and house leasing services. The firm distributes its products both in the domestic market and to overseas markets.

Intrinsic Value
56.99 CNY
Undervaluation 37%
Intrinsic Value
Price
Q

See Also

What is Qingdao NovelBeam Technology Co Ltd's Total Current Assets?
Total Current Assets
904.9m CNY

Based on the financial report for Dec 31, 2023, Qingdao NovelBeam Technology Co Ltd's Total Current Assets amounts to 904.9m CNY.

What is Qingdao NovelBeam Technology Co Ltd's Total Current Assets growth rate?
Total Current Assets CAGR 5Y
45%

Over the last year, the Total Current Assets growth was -1%. The average annual Total Current Assets growth rates for Qingdao NovelBeam Technology Co Ltd have been 67% over the past three years , 45% over the past five years .

Back to Top